CD44 and breast carcinoma: The expression levels of cancer stem cell genes CD44, CD24, and related miRNAs miR590-3p, miR599, and miR399-3p were aimed to be investigated before and after neoadjuvant therapy in breast cancer patients in this cross-sectional observational study.